Tung et al. (2022) identified that penfluridol, a dopamine receptor D2 (DRD2)-targeting antipsychotic, could suppress cancer stemness by inducing autophagy-mediated apoptosis in RCC. Here, DRD2 is linked to renal cell adenocarcinoma.